No abstract available
Keywords:
Adrenomedullin; Anti-oxidants; Cardiomyopathy; Diabetes; New drugs; Novel targets; Nrf2 pathway; Pyruvate dehydrogenase kinase; SERCA.
MeSH terms
-
Diabetic Cardiomyopathies / metabolism*
-
Diabetic Cardiomyopathies / therapy*
-
Humans
-
Insulin Resistance
-
MicroRNAs / therapeutic use
-
Molecular Targeted Therapy
-
Oxidative Stress
-
Renin-Angiotensin System